Emanuel Kanal

Emanuel Kanal

Auto-generated profile, based on publicly available information

Emanuel Kanal

Department of Radiology University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2013 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
PDF file
ESExpert Panel On Mr Safety
Expert Panel On Mr Safety
EKEmanuel Kanal
Emanuel Kanal
ABA. James Barkovich
A. James Barkovich
CBCharlotte Bell
Charlotte Bell
JBJames P. Borgstede
James P. Borgstede
DHDina Hernandez
Dina Hernandez

1 December 2016 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
EKEmanuel Kanal
Emanuel Kanal

1 September 2019 in Radiology
Verified
Journal Article
Closed access
MHMichael N. Hoff
Michael N. Hoff
AMAlexander McKinney
Alexander McKinney
FSFrank G. Shellock
Frank G. Shellock
URUlrich Rassner
Ulrich Rassner
TGTobias Gilk
Tobias Gilk
EKEmanuel Kanal
Emanuel Kanal
Although 7-T MRI has recently received approval for use in clinical patient care, there are distinct safety issues associated with this relatively high magnetic field. Forces on metallic implants and radiofrequency power deposition and heating are safety considerations at 7 T. Patient bioeffects such as vertigo, dizziness, false feelings of motion, nausea, nystagmus, magnetophosphenes, and electrogustatory effects are more common and potentially more pronounced at 7 T than at lower field strengths. Herein the authors review safety issues associated with 7-T MRI. The rationale for safety concerns at this field strength are discussed as well as potential approaches to mitigate risk to patients and health care professionals.

2 December 2008 in Trials
Verified
Journal Article
Open access
PDF file
Richard SuttonRichard Sutton
Richard Sutton
EKEmanuel Kanal
Emanuel Kanal
BWBruce L Wilkoff
Bruce L Wilkoff
DBDavid Bello
David Bello
RLRoger Luechinger
Roger Luechinger
TSTorsten Sommer
Torsten Sommer
Magnetic Resonance Imaging (MRI) of patients with implanted cardiac devices is currently considered hazardous due to potential for electromagnetic interference to the patient and pacemaker system. With approximately 60 million MRI scans performed worldwide per year, an estimated majority of pacemaker patients may develop an indication for an MRI during the lifetime of their pacemakers, suggesting that safe use of pacemakers in the MRI environment would be clinically valuable. A new pacing system (Medtronic EnRhythm MRI™ SureScan™ and CapSureFix MRI™ leads) has been designed and pre-clinically tested for safe use in the MRI environment. The EnRhythm MRI study is designed to confirm the safety and efficacy of this new pacing system.

1 January 2008 in Radiology
Verified
Journal Article
Closed access
EKEmanuel Kanal
Emanuel Kanal
DBDale R. Broome
Dale R. Broome
DMDiego R. Martin
Diego R. Martin
HTHenrik S. Thomsen
Henrik S. Thomsen

1 July 2020 in Radiology
Verified
Journal Article
Closed access
NNNghi Nguyen
Nghi Nguyen
TMTheodore T. Molnar
Theodore T. Molnar
LCLucas G. Cummin
Lucas G. Cummin
EKEmanuel Kanal
Emanuel Kanal
Gadobenate dimeglumine administrations lead to increased MRI signal intensity in the dentate nucleus. Background Increased cerebral signal intensity (SI) has been reported in patients undergoing MRI with gadolinium-based contrast agents (GBCAs). Published data on gadobenate dimeglumine have been so...